DE69104314D1 - Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen. - Google Patents

Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen.

Info

Publication number
DE69104314D1
DE69104314D1 DE69104314T DE69104314T DE69104314D1 DE 69104314 D1 DE69104314 D1 DE 69104314D1 DE 69104314 T DE69104314 T DE 69104314T DE 69104314 T DE69104314 T DE 69104314T DE 69104314 D1 DE69104314 D1 DE 69104314D1
Authority
DE
Germany
Prior art keywords
dimethylamino
propyl
treatment
cerebrovascular disorders
phenylphthalenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69104314T
Other languages
English (en)
Other versions
DE69104314T2 (de
Inventor
Yoshiaki Tanaka
Naomi Kobayashi
Tadashi Kurimoto
Yugo Ikeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26066379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69104314(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of DE69104314D1 publication Critical patent/DE69104314D1/de
Application granted granted Critical
Publication of DE69104314T2 publication Critical patent/DE69104314T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69104314T 1990-09-06 1991-08-16 Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen. Expired - Lifetime DE69104314T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK213290A DK213290D0 (da) 1990-09-06 1990-09-06 Treatment of cerebrovascular disorders
SG165594A SG165594G (en) 1990-09-06 1994-11-16 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders

Publications (2)

Publication Number Publication Date
DE69104314D1 true DE69104314D1 (de) 1994-11-03
DE69104314T2 DE69104314T2 (de) 1995-02-16

Family

ID=26066379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69104314T Expired - Lifetime DE69104314T2 (de) 1990-09-06 1991-08-16 Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen.

Country Status (14)

Country Link
EP (1) EP0474580B1 (de)
JP (1) JPH085787B2 (de)
KR (1) KR970002246B1 (de)
AT (1) ATE112166T1 (de)
AU (1) AU644204B2 (de)
CA (1) CA2049368C (de)
DE (1) DE69104314T2 (de)
DK (2) DK213290D0 (de)
HK (1) HK21595A (de)
IE (1) IE72160B1 (de)
IL (1) IL98968A (de)
NZ (1) NZ239437A (de)
SG (1) SG165594G (de)
ZA (1) ZA916187B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3526581B2 (ja) * 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
JP4674339B2 (ja) * 1998-08-07 2011-04-20 三菱化学株式会社 脳損傷の予防・治療剤
PL199423B1 (pl) * 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
TR200101796T2 (tr) 1998-12-23 2001-11-21 H. Lundbeck A/S 5-Siyanofitalitin preparasyonuna yönelik metot
ATE237604T1 (de) 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
BG64901B1 (bg) * 2000-05-29 2006-08-31 H. Lundbeck A/S Метод за получаване на циталопрам
CA2354880C (en) * 2000-08-18 2003-06-03 H. Lundbeck A/S Method for the preparation of citalopram
IL147226A (en) * 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure cithalopram
BG65515B1 (bg) * 2002-07-26 2008-10-31 H. Lundbeck A/S Метод за получаване на 5-цианофталид
EP1691811B1 (de) 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Kombination aus einem sedativum und einem neurotransmitter-modulator und verfahren zur verbesserung der schlafqualität und zur behandlung von depression
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
DE102007051090A1 (de) 2007-06-28 2009-01-08 Charité - Universitätsmedizin Berlin SSRI zur Behandlung neuronaler Krankheiten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten
CN104005415B (zh) * 2014-02-18 2015-12-02 中铁十六局集团北京轨道交通工程建设有限公司 微风化花岗岩中地下连续墙的高效成槽施工方法
CN106871753B (zh) * 2017-01-04 2018-10-16 中铁隧道集团有限公司 一种用于提高水平岩层隧道成型的装药方法

Also Published As

Publication number Publication date
JPH085787B2 (ja) 1996-01-24
IL98968A (en) 1996-06-18
ATE112166T1 (de) 1994-10-15
AU644204B2 (en) 1993-12-02
EP0474580A3 (en) 1992-06-03
CA2049368A1 (en) 1992-03-07
ZA916187B (en) 1992-04-29
SG165594G (en) 1995-05-12
IE72160B1 (en) 1997-03-26
KR920005983A (ko) 1992-04-27
IL98968A0 (en) 1992-07-15
CA2049368C (en) 2001-10-23
DK0474580T3 (da) 1995-04-03
KR970002246B1 (ko) 1997-02-26
AU8259491A (en) 1992-03-12
JPH04244024A (ja) 1992-09-01
EP0474580B1 (de) 1994-09-28
DE69104314T2 (de) 1995-02-16
IE912682A1 (en) 1992-03-11
HK21595A (en) 1995-02-24
DK213290D0 (da) 1990-09-06
NZ239437A (en) 1997-02-24
EP0474580A2 (de) 1992-03-11

Similar Documents

Publication Publication Date Title
DE69104314D1 (de) Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen.
NO922147D0 (no) Heterocykliske derivater
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
DE59203976D1 (de) Hydantoinderivate.
FI913478A0 (fi) Diazinderivat.
ATE106404T1 (de) Angiotensin-ii-antagonisten.
ATE245418T1 (de) Verwendung von thiazolidindionen zur behandlung von atherosklerose und essstörungen
DE68923151D1 (de) Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen.
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE69018726D1 (de) Cumarinderivate, ihre Herstellung und ihre Verwendung zur Behandlung von zerebrovaskulären Störungen.
ATE85334T1 (de) Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung.
ES8602723A1 (es) Un procedimiento para la preparacion de nuevas n-bencil-propilaminas sustituidas.
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
ATE121623T1 (de) Verwendung von quinazolinen zur herstellung eines arzneimittels zur behandlung und vorbeugung von arrhythmie.
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE53205T1 (de) Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung.
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
RO95572A2 (ro) Procedeu pentru prepararea unor derivati de 1,3-oxazolidin-2-ona
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition